Canada's changing policies and history of psychedelic use for end-of-life distress

Canada's evolving attitudes toward psychedelic interventions in palliative and end-of-life care reflect a departure from historically prohibitionist policies.

• There is growing recognition of the therapeutic potential of psychedelics for individuals experiencing end-of-life distress.
• International regulatory developments in the United States, Australia, and parts of Europe indicate a trend toward greater acceptance of psychedelics in clinical settings.
• Canada's historical role in palliative care and its frameworks emphasizing holistic suffering approaches influence national discussions about autonomy and end-of-life care.
• Rising public demand and incremental provincial changes may position Canada uniquely for clinical integration of psychedelics in palliative care.
• Canadian drug policy shows significant variability across substances and provinces, highlighting the political nature of reform.

Simplified